tiprankstipranks

BeiGene granted orphan designation for sonrotoclax

BeiGene’s (ONC) sonrotoclax was granted FDA orphan designation as a treatment of myelodysplastic syndromes, according to a post to the agency’s website.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

1